Re:New Psychedelic Entactogens
by boring_twenties on Monday October 24, 2022 @10:21PM
(#33325408)
Psilocybin, DMT, LSD and mescaline all have vastly different effects from MDMA. That's why MDMA is called an entactogen or empathogen, and not a psychedelic.
Mescaline is a substituted amphetamine just like MDMA. As is the antidepressant buproprion (Wellbutrin). And a variety of very strong hallucinogens.
Re:New Psychedelic Entactogens
by Synaesthesia on Tuesday October 25, 2022 @02:47AM
(#33327066)
MDMA can be problematic like that, it has a host of side effects, particularly at higher doses and can be mildly habit forming. The effects also wane very rapidly with repeated use and the side effects become much worse. A valuable drug but one to use with caution.
I would definitely stick to the below 120mg dosages, these pills with 220mg are way too much!
https://en.wikipedia.org/wiki/Amphetamine
The paper cited on the potential similarity to psilocybin and LSD (which exert their activity through the 5-HT2A receptor) is behind a paywall and mice of course are not humans, so that's very speculative.
However, why mess around with compounds with unknown metabolic breakdown behavior, with unknown side effects and activity in humans, when the existing psychedelics (such as psilocybin, DMT, LSD and mescaline) are fairly well understood in terms of effects on humans?